Clinical Trial Update: Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining venetoclax plus azacytidine with a modified Busulfan/cyclophosphamide (BUCY) conditioning regimen for patients with ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Venetoclax (venetoclax)
• azacytidine (azacitidine)
• modified BUCY conditioning regimen

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN